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Abstract 
The purpose of this integrative literature review is to determine if an exercise program has an 
effect on reducing cancer-related fatigue in women receiving treatment for non-metastatic breast 
cancer.  Key words used in the database search parameters of nursing (CINAHL) and medical 
(PubMed) literature (published 2002 to 2012) included “breast cancer,” “exercise,” and 
“fatigue.”  Data analysis and findings of the studies demonstrated that both supervised and 
home-based exercise programs are safe and effective in reducing cancer-related fatigue in the 
non-metastatic breast cancer patient population.  However, additional studies need to be 
completed before definitive conclusions can be made, especially in regards to the specific type, 
duration, and intensity of exercise prescription needed for each patient.  Findings of these studies 
can be applied to the clinical practice of an advanced practice registered nurse by providing 
evidence on the importance of screening for and providing recommendations to treat cancer-
related fatigue in women treated for non-metastatic breast cancer. 
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The Effect of Exercise on Cancer-related Fatigue in Women Receiving Treatment for  
Non-metastatic Breast Cancer: 
Evidence-based Practice Literature Review 
 Nearly twelve-percent of women in the United States will be diagnosed with invasive 
breast cancer throughout their lifetime (American Cancer Society [ACS], 2012).  With the large 
number of women diagnosed and receiving treatment for non-metastatic breast cancer, it is 
important that providers understand specific side effects related to the diagnosis and associated 
therapies and how they affect each patient.  One of the most debilitating side effects of battling 
breast cancer and further receiving adjuvant therapies such as chemotherapy and radiation 
therapy to treat the cancer is cancer-related fatigue (CRF) (Hsieh, Sprod, Hydock, Carter, 
Hayward, & Schneider, 2008).  According to the National Comprehensive Cancer Network 
(NCCN) (2011), “cancer-related fatigue is a distressing persistent, subjective sense of physical, 
emotional and/or cognitive tiredness or exhaustion related to cancer or cancer treatment that is 
not proportional to recent activity and interferes with usual functioning” (p. FT-1).  CRF 
significantly affects patients’ quality of life (QoL) by making patients too tired to participate in 
activities they enjoyed prior to their cancer diagnosis and treatment experience (NCCN, 2011).   
 Cancer-related fatigue is not related to rest and is often worse for patients who are 
actively receiving treatment for their cancer (Silver, 2006).  CRF is estimated to be experienced 
by nearly 80% of women who receive chemotherapy and/or radiation therapy (NCCN, 2011) and 
is often reported as more debilitating than pain, nausea or constipation—all conditions which are 
treatable with medications (NCCN, 2011).  CRF is a cumulative symptom which directly affects 
patients’ QoL and can last for weeks, months or even years during and after treatment has 
EXERCISE AND CANCER-RELATED FATIGUE 4 
subsided (Silver, 2006).  This makes it incredibly important for oncology providers to assess for 
and provide interventions to help reduce or eliminate this debilitating symptom.   
 Cancer-related fatigue often presents as a combination of symptoms and may be due to 
side effects from chemotherapy and radiation therapy, direct effect from the tumor, decreased 
nutritional intake, and lack of sleep, to name a few (NCCN, 2011; Silver, 2006).  Also, many 
symptoms such as pain, distress, and anemia occur simultaneously with fatigue and may be the 
contributing factor(s) of women developing CRF during their cancer treatment (NCCN, 2011).  
Treatments such as chemotherapy and radiation therapy are often incorporated as adjuvant 
therapies—additional cancer treatment given after the primary treatment to lower the risk that the 
cancer will come back—with the intent to eliminate microscopic cancer cells not removed during 
surgery and to lower the risk of reoccurrence of the woman’s breast cancer (National Cancer 
Institute, n.d.; Hsieh et al., 2008).  However, these therapies do not come without significant side 
effects.  
 Cancer treatments such as chemotherapy and radiation therapy cause CRF in a variety of 
ways.  “Radiation therapy has been implicated in the occurrence of interstitial myocardial 
fibrosis and coronary and carotid artery arteriosclerosis” (Hsieh et al., 2008, p. 910) leading to 
CRF.  Radiation therapy causes CRF through a cumulative effect; patients receiving adjuvant 
radiation therapy often do not feel the effects of treatment until 2-3 weeks after therapy has 
ceased (Silver, 2006). Chemotherapy medications not only target the malignant, cancer-causing 
cells; they also target the body’s healthy, non-cancerous cells.  The amount of energy that is 
required to heal the damage which has been done to healthy tissues can lead to extreme feelings 
of fatigue (Silver, 2006).  Side effects of chemotherapy, such as nausea, mouth sores, taste 
changes, diarrhea and heartburn can alter one’s ability and desire to consume adequate nutrition 
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needed to maintain an appropriate amount of energy to fight the breast cancer (Silver, 2006).  
Chemotherapy can lead to a reduction in blood counts required to carry oxygen to tissues, which 
consequently leads to development of anemia and a significant amount of fatigue.  It is estimated 
that 70 percent of patients develop anemia during chemotherapy treatment (Cleveland Clinic, 
2011).  One of the only ways to combat this type of fatigue without discontinuing treatment is by 
recognizing and treating the anemia with pharmacologic intervention, such as erythropoietin 
injection (NCCN, 2011).   
 When a patient receiving treatment for non-metastatic breast cancer complains of fatigue, 
it is essential for oncology providers to screen for multiple symptoms to determine the cause or 
offending symptom(s) of fatigue to aid them in potentially eliminating the patient’s symptoms 
(NCCN, 2011).  If any treatable contributing factors, such as nutritional abnormalities or anemia 
are discovered during a provider’s assessment of CRF, those conditions need to be treated to help 
reduce the patient’s reported fatigue (NCCN, 2011).  However, often CRF is not due to a 
pharmacologically-treated condition and consequently, a provider should be aware of non-
pharmacologic therapies that help reduce extremely distressing CRF.  A non-pharmacologic 
therapy researched recently is the prescription of an exercise program, either home-based or 
supervised to treat cancer-related fatigue.  The rationale for using exercise to treat cancer-related 
fatigue, according to Mock, Frangakis, Davidson, Ropka, Pickett, Poniatowski, Stewart, 
Cameron, Zawacki, Podewils, Cohen, & McCorkle (2005):  
 The combined effects of toxic treatments plus decreased levels of activity during   
  treatment reduce the capacity for physical performance. A reduced functional  
  capacity means that the cancer patient expends greater effort relative to maximal  
  ability to perform usual activities, thus leading to higher levels of fatigue.   
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  Exercise training attenuates the loss and even increases functional capacity,  
  resulting in reduced effort and decreased fatigue at any level of work. (p. 465) 
 The American College of Sports Medicine (ACSM) (2012) recommends that all 
Americans partake in at least 150 minutes of moderate-intensity exercise each week to maintain 
a healthy lifestyle.  According to the Centers for Disease Control and Prevention (CDC), 
moderate-intensity physical activity is when “a person’s target heart rate [is] 50 to 70% of his or 
her maximum heart rate” (CDC, 2011b, para. 2).  A person’s maximum heart rate (MHR) is 
determined by subtracting his/her age from 220.  To determine the percentage of MHR, one 
would multiply his/her MHR by the percentage that he/she is interested in calculating (for 
example, multiply by 0.50 to determine 50% of MHR) (CDC, 2011b).  Examples of moderate-
intensity exercise include walking briskly, water aerobics, riding a bicycle slower than 10 miles 
per hour, or partaking in general gardening (CDC, 2011a).  The CDC recommends that people 
use the “talk test” to determine the level of exercise intensity that they are doing at the present 
time.  According to the CDC, “as a rule of thumb, if you’re doing moderate-intensity activity you 
can talk, but not sing, during the activity” (CDC, 2011a, para. 3).  The U.S. Department of 
Health & Human Services (2008) maintains a similar stance to the CDC and ACSM; they 
recommend obtaining 150 to 300 hours of moderate-intensity exercise per week, noting that this 
intensity of exercise provides substantial amounts of health benefits for both the healthy and 
oncology patient populations.  
Research Question 
 The research question addressed in this integrative review is: In women with non-
metastatic breast cancer receiving adjuvant chemotherapy and/or radiation therapy, does the 
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prescription of a home-based or supervised exercise program versus usual care decrease the 
severity of cancer-related fatigue? 
Critical Appraisal of the Evidence 
Theoretical Background of Exercise as a Cancer-Related Fatigue Intervention  
 Fernando Carlos Dimeo (2001) expanded on research conducted in 1983 by Mary 
Winningham by exploring the physiologic and pathologic causes of cancer-related fatigue and 
further suggested that exercise may serve as an effective intervention to treat this debilitating 
side effect in patients with non-metastatic breast cancer.  Dimeo noted that when fatigue occurs 
during daily activities, is not resolved with rest, occurs for a prolonged duration of time and 
greatly affects patient’s normal activities of daily living, it is therefore classified as pathologic 
and requires provider’s interventions.  The effects of chemotherapy and radiation therapy on the 
delivery of oxygen and energy production throughout the body significantly contribute to the 
cause of cancer-related fatigue.  In past years, physicians’ recommendation for fatigue was to 
rest; this resulted in a negative outcome of muscle wasting and loss of fitness ability, further 
increasing a patient’s fatigue.  Dimeo noted previous research findings on positive effects of 
exercise on cancer-related fatigue in patients with peripheral stem cell transplantation and further 
suggested research focus on the effect of exercise on cancer-related fatigue in patients with 
breast cancer.  
Data Analysis 
 A thorough database search was conducted looking at both nursing (CINAHL) and 
medical (PubMed) literature published between the years of 2002 to 2012.  Key words used in 
the database search parameters were “breast cancer,” “exercise,” and “fatigue.”  Articles were 
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initially included if the title and abstract included the words “cancer,” exercise,” and “fatigue,” 
and a total of twenty-two articles were initially selected that fit within the stated parameters.  
Each study was reviewed for further inclusion criteria, specifically the participants having a 
primary breast cancer diagnosis and receiving current adjuvant treatment.  It is important to note 
that both meta-analyses (Cramp, 2010; Velthius, Agasi-Idenburg, Aufdemkampe, & Wittink, 
2010) in this review researched patients with various types of cancer—not just breast cancer—
experiencing cancer-related fatigue; however, in both reviews, a majority of the studies analyzed 
were completed on women with non-metastatic breast cancer.  It was personal clinical 
knowledge that the NCCN (2011) maintained a published guideline on cancer-related fatigue; as 
a result, this guideline was analyzed and referenced as supportive material for this literature 
review.   
 The Johns Hopkins Nursing Evidence-Based Practice (JHNEBP) evidence rating scales 
(Newhouse, Dearholt, Poe, Pugh, & White, 2005) were used to analyze the included studies and 
meta-analyses in this integrative review.  The JHNEBP rating scales systematically analyze the 
article’s strength of study design, research strategies, results, conclusions and if the study’s 
findings will affect clinical practice (Newhouse et al., 2005).  A total of six articles were 
determined to be most inclusive for this literature review.  All of the included articles were 
published between the years of 2005 to 2011.  The research was completed on populations 
residing in a diverse population of countries, including Taiwan, Canada, the United States, and 
countries throughout Europe.  The sample sizes in all of the articles reviewed varied from 8 to 
377 total participants.   
 The five quantitative studies in this review all had a similar purpose of exploring the 
effect of exercise on cancer-related fatigue in women with non-metastatic breast cancer (Wang, 
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Boekmke, Wu, Dickerson, & Fisher, 2011; Mock et al., 2005; Hsieh et al., 2008; Cramp, 2008; 
Velthius et al., 2010).  There was a noticeable pattern of results between all five studies; they all 
found that exercise (either home-based or supervised) programs have a significant effect on 
reducing CRF (Mock et al., 2005; Wang et al., 2011; Hsieh et al., 2008; Cramp, 2008; Velthius 
et al., 2010; Ingram, Wessel, & Courneya, 2010).  The analyzed studies and meta-analyses in this 
review were all quantitative in design except for one study, which was qualitative and purposely 
selected to demonstrate patient perspective of participating in an exercise program during cancer 
treatment (Ingram et al., 2010).   
 The research designs—randomized controlled trials, experimental, quasi-experimental 
and meta-analyses—were appropriate for the research problems and hypotheses being studied 
(Mock et al., 2005; Wang et al., 2011; Hsieh et al., 2008; Cramp, 2008; Velthius et al., 2010).  
All of the research studies included an intervention group consisting of an exercise program and 
a control group, which was typically usual care.  The experimental, longitudinal study by Wang 
et al. (2011) was unique in that it measured women’s levels of fatigue at four predetermined time 
points and that it followed patients prior to their initial surgery to remove the breast cancer.  The 
sampling of the studies and demographics of the participants were included in all of the analyzed 
studies, noting the mean age of the women and often the education level for the participants 
(Mock et al., 2005; Wang et al., 2011; Hsieh et al., 2008; Cramp, 2008; Velthius et al., 2010).  
The research studies by Mock et al. (2005), Hsieh et al. (2008), Ingram et al. (2010), Cramp 
(2008), and Velthius et al. (2010) did not note the race or socioeconomic status of the 
participants.  Consequently, it could be argued that it is difficult to generalize the data to a more 
diverse, multicultural patient population.  The experimental, longitudinal study by Wang et al. 
(2011), however, was conducted on a Taiwanese breast cancer population, and the results of this 
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study are important for this review because they demonstrate the application of this research on a 
diverse population.   
 The participants in all of the experimental studies were first screened for exclusion 
criteria, including conditions or symptoms which contradicted exercise and would place the 
patients at further harm if they were to participate in the studies (Mock et al., 2005; Wang et al., 
2011; Hsieh et al., 2008; Cramp, 2008; Velthius et al., 2010).  Also, many of the studies included 
frequent interactions between the researchers and participants (Mock et al., 2005; Wang et al., 
2011; Hsieh et al., 2008) and the modification of the exercise programs if the patients’ health 
conditions changed throughout the studies, further implying that the researchers did not want to 
cause the participants harm during the study periods (Mock et al., 2005; Hsieh et al., 2008).  The 
primary means of data collection in all of the studies included the use of questionnaires, 
interviews, self-journals, and scales, which furthermore did not place the participants at harm 
(Mock et al., 2005; Wang et al., 2011; Hsieh et al., 2008; Cramp, 2008; Velthius et al., 2010). 
Research-Based Evidence 
 Experimental and quasi-experimental studies:  Mock et al. (2005) conducted the first 
multi-institutional prospective, randomized controlled trial exploring the effects of a moderate-
intensity home-based walking exercise program on fatigue levels in women with non-metastatic 
breast cancer while receiving adjuvant chemotherapy or radiation therapy.  The stratified 
assignment of participants to groups defined by their first adjuvant treatment and then further 
randomization to intervention or control groups supported the strength of the study’s design, one 
that was similar to a clinical trial design.  Mock et al.’s study was conducted at four university 
teaching hospitals and four community cancer centers located on the East coast of the United 
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States.  The sample size was large with a total of 119 women, including 57% who received 
radiation and 42% who received chemotherapy.  As previously mentioned, the participants were 
randomized to intervention and control groups, but the researchers were not blind to who was in 
either group, which was noted by the researchers as a potential limitation of the study.  The 
researchers attempted to control this by having the participants self-administer questionnaires 
and by using numbers, not names, on all of the data forms (Mock et al., 2005).   
 The primary outcome of the study was fatigue, measured both pre-therapy and post-
therapy using the Piper Fatigue Scale (Mock et al., 2005).  The researchers also studied the 
physical functioning and activity levels of the participants, using the 12-minute Walk Test, the 
Medical Outcomes Study Short Health Form, and the Physical Activity Questionnaire as 
measurement tools.  The p value, set to define statistical significance, was a strength of the study 
with p = 0.03.  The statistical analysis of data included looking at the “intent-to-treat effect” and 
the “effect of actually exercising”, measured by the method of “instrumental variables with 
principle stratification (IV/PS)” (Mock et al., 2005, p. 467).  This method estimates each 
participant’s adherence to her assigned group and further assigns each participant to a principal 
strata group: never-taker; always-taker; full-complier; or defier.  This method helps to more 
accurately analyze the data as some participants’ data, specifically the never-takers and always-
takers, will not accurately reflect their randomization group due to their principal strata.  This 
principle is also known as “complier-average-causal effect (CACE);” it only focuses on the data 
of the full-compliers (the participants who fully follow the intervention or control to which they 
are assigned) (Mock et al., 2005, p. 468).  
 The mean fatigue scores (Piper Fatigue Scale) for all participants at the beginning of the 
study was 2.42 (SD = 2.46) and increased to 2.20 (SD = 2.52) to 3.75 (SD = 2.41) for patients 
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receiving radiation therapy and 2.77 (SD = 2.34) to 3.46 (SD = 2.60) for patients receiving 
chemotherapy (Mock et al., 2005).  For full-compliers assigned to the usual care group, the 
estimated change in fatigue score from baseline was 1.17; and the change in fatigue score for the 
full-compliers in the exercise group was -0.86.  Through applying the principle of CACE, the 
difference in mean fatigue outcomes was -2.03, which demonstrates statistical significance of 
using exercise to combat cancer-related fatigue.  Using the JHNEBP evidence rating scales, this 
prospective, randomized controlled trial has a strength of evidence rating of I and a quality rating 
of A/high (Newhouse et al., 2005).   
 Wang et al. (2011) completed an experimental, longitudinal research study using a 
walking program for Taiwanese women with early-stage breast cancer.  This was the first study 
of this kind in Taiwan, and was unique because the study was started prior to the women 
completing their initial surgery and adjuvant chemotherapy treatments.  The study looked at 
various outcomes, including QoL, fatigue and sleep disturbance.  The sample for this study was 
medium in size (N=72) and included an exercise group (N=35) and control group (N=37).  The 
participants were recruited by convenience sampling with randomization to exercise and control 
groups.  The use of convenience sampling is a limitation of Wang et al.’s study; however, the use 
of randomization to both an intervention and control group was a noted strength of the study.  
The completion rate for the study was 80.6%; and the compliance rate for the exercise group was 
93.8%, with both rates notably higher than the study’s comparison literature review and with 
both rates supporting the validity of the study.   
 The Functional Assessment of Chronic Illness Treatment – Fatigue (FACIT-F) 
instrument was used to measure the occurrence of the outcome variable of fatigue (Wang et al., 
2011).  Repeated-measure analysis of variance (RMANOVA) was ultimately used to analyze the 
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data of the study due to the hierarchical linear model (HLM), which was the main analysis 
method to measure change of the clinical outcomes over a 6-week time period, not serving as an 
appropriate means for measuring change of fatigue over the study period.  The results of the 
study indicated that “subjects in the exercise group had less fatigue than those in the usual-care 
group and supported findings of most exercise interventional studies” (Wang et al., 2011, p. 
E10).  Significant differences in fatigue between the exercise and usual care groups was noted at 
nadir time (time 3 = 8.52, P < .001) and at the end of the exercise program (time 4 = 5.78, P < 
.001).  It is important to note that the change in fatigue levels was greater for the exercise group; 
however, the results were not statistically significant (F1,60 = 9.74, P = .003) (Wang et al., 2011).  
Using the JHNEBP evidence rating scales, this experimental, longitudinal study has a strength of 
evidence rating of I and a quality rating of B/good (Newhouse et al., 2005).   
 Hsieh et al. (2008) researched the effects of moderate-intensity, individually-prescribed, 
supervised exercise on cancer-related fatigue and cardiopulmonary function in women with 
breast cancer immediately following treatment completion.  The participants of this quasi-
experimental study were selected through convenience sampling at the Rocky Mountain Cancer 
Rehabilitation Institute, which is a noted by the researchers to be a limitation of the study.  The 
rather large sample (N=96) was divided into four non-randomized groups: surgery alone; surgery 
and chemotherapy; surgery and radiation; and surgery, chemotherapy and radiation.  The revised 
Piper Fatigue Scale was used to assess the participants’ cancer-related fatigue.  One-way analysis 
of variance (ANOVA) was used to analyze the study’s data and statistical significance was set at 
P ≤ 0.05.  In addition to studying the effect of exercise on fatigue, the researchers also looked at 
the effect of exercise on cardiopulmonary function; results of those outcomes will not be 
discussed in this review. 
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 The results of the study indicated that moderate-intensity, individualized, prescribed 
exercise reduces fatigue in breast cancer patients who are monitored immediately after 
completing adjuvant therapy (Hsieh et al., 2008).  The exercise intervention resulted in 
significant reductions (P < 0.05) in fatigue in multiple categories—behavioral fatigue; affective 
fatigue; sensory fatigue; cognitive and mood fatigue; and total fatigue—for the 
surgery/chemotherapy, surgery/radiation therapy, and surgery/chemotherapy/radiation therapy 
groups.  The surgery and radiation therapy group had the greatest reduction in behavioral (-
51.05% change), affective (-36.36% change), sensory (-46.03% change), and total fatigue (-
39.47% change).  The researchers noted that the inclusion of a non-exercise, control group would 
have strengthened the study’s results (Hsieh et al., 2008).  Using the JHNEBP evidence rating 
scales, this study quasi-experimental, study has a strength of evidence rating of II and a quality 
rating of B/good (Newhouse et al., 2005).   
Meta Analyses of Randomized Controlled Trials 
 Cramp (2008) completed a meta-analysis which was included in the Cochrane Database 
of Systematic Reviews of twenty-eight randomized controlled trials (RCTs) (N = 2083 
participants) evaluating the effect of exercise on cancer-related fatigue both during and after 
cancer treatment.  Cramp’s review looked at patients with various types of cancer; however, the 
majority of the studies (N = 16 studies; N = 1172 participants) researched patients with breast 
cancer.  Cramp searched all relevant databases (a total of eight), oncology journals and reference 
lists for additional articles not found in the initial database searches.  The mode and intensity of 
exercise, including both home-based and supervised exercise programs, varied among the 
reviewed studies.  There were other outcome variables that were researched in the RCTs 
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analyzed by Cramp, including aerobic capacity, QoL, anxiety, depression, self-efficacy, and 
other long-term outcomes of exercise. 
 Cramp (2008) used a meta-analysis to look at both post-test means and change data 
between the exercise intervention groups and control groups.  For the post-test means results, a 
total of 920 participants’ data was analyzed for the exercise intervention and 742 participants’ 
data was analyzed for the control group.  Cramp determined that the intervention of exercise was 
statistically more significant than the control group on the outcome of fatigue (SMD -0.23, 95% 
CIs -0.33 to -0.13).  A total of 454 participants received the exercise intervention and 399 
participants were part of the control group in the change data analysis.  Cramp noted, “at the end 
of the intervention periods exercise was statistically more effective than the control intervention 
(SMD -0.23, 95% CIs -0.36 to -0.09)” (p. 7).  Cramp determined through this meta-analysis that 
exercise intervention has a statistically significant impact on CRF both during adjuvant therapy 
and post-therapy.   
 Cramp (2008) noted that limitations of the review included, but were not limited to: a 
diverse range of studies with small numbers of participants; lack of statistical heterogeneity in 
RCTs completed during clinical treatment; the publishing of studies in only the English language 
which may reflect selective publication with statistically significant data only; and the possibility 
of the previous researchers selectively reporting only statistically significant data.  The exercise 
intervention in only nine of the 28 reviewed RCTs was in congruence with the ACSM 
recommendation for 30 minutes of moderate-intensity exercise, 5 days per week.  This finding 
may be suggestive that the ACSM guidelines are not appropriate for recommendation 
specifically to cancer patients and that the development of new cancer-specific exercise 
recommendations may be necessary in the future (Cramp, 2008).  Using the JHNEBP evidence 
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rating scales, this meta-analysis review has a strength of evidence rating of I and a quality rating 
of A/high, making the results of this review very pertinent and applicable to clinical practice 
(Newhouse et al., 2005).   
 Velthius et al. (2010) completed a meta-analysis of 18 randomized controlled trials that 
were conducted to determine the short- and long-term effectiveness of different exercise 
prescriptions on cancer-related fatigue experienced during treatment.  Of the 18 total analyzed 
studies, 12 studies were conducted on breast cancer patients while receiving treatment.  The 
exercise intervention in these studies ranged from home-based aerobic and/or resistance exercise 
to supervised aerobic and/or resistance exercise.  All of the 12 studies had a control usual care 
group, except one study’s control group consisted of a placebo stretching protocol.  The main 
outcome variable was patient-reported fatigue which was measured by various questionnaires 
and scales, including the Piper Fatigue Scale and revised Piper Fatigue Scale; the Functional 
Assessment Cancer Therapy-Fatigue and Anemia scales, Profile of Mood States, Functional 
Assessment of Cancer Therapy-Fatigue, Brief Fatigue Inventory, and the Symptom Assessment 
Scale.  The methodological quality of the study (0.7 with standard error of 0.06) was determined 
by the researchers with the use of the PEDro scale.  Six of the twelve RCTs in breast cancer 
patients had a methodological total score of >5 (total score possible = 8) (Velthius et al., 2010).   
 This meta-analysis used multiple subgroup analyses of pooled data from high-quality 
studies to determine if there were significant results to draw conclusions on the different exercise 
programs (Velthius et al., 2010).  The researchers completed a subgroup analysis on three high-
quality studies looking at supervised, aerobic exercise; these three studies included a total of 340 
patients and demonstrated a medium-sized and significant reduction in CRF (SMD 0.30, 95% 
confidence interval 0.09 to 0.51).  In another subgroup analysis of two high-quality studies (total 
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of 128 patients) looking at a home-based exercise program, the researchers determined a small, 
non-significant reduction in CRF (SMD 0.10, 95% confidence interval -0.25 to 0.45).  
Consequently, the researchers concluded that supervised, aerobic exercise programs were more 
effective in reducing CRF than home-based exercise programs.  They further stated that 
supervised exercise programs may be more effective in the short-term period surrounding 
adjuvant treatment, possibly due to the individual not being able to effectively judge the intensity 
or adherence to the exercise program that is necessary to achieve positive physiologic results 
(Velthius et al., 2010).    
 Velthius et al. (2010) state that the general exercise prescription for breast cancer patients 
currently receiving or just recently completed adjuvant therapy is “low to moderate intensity, 
regular frequency (three to five times a week) for at least 20 minutes per session, involving 
aerobic, resistance, or mixed exercise types” (p. 219).  Because there were very few adverse 
effects associated with both the home-based and supervised exercise programs (total of eight, or 
0.72%) and because of the participants’ moderate to excellent adherence in the reviewed studies, 
the researchers state that these programs are safe and do not pose any health risks to patients with 
non-metastatic breast cancer who are receiving adjuvant treatment (Velthius et al., 2010).  Using 
the JHNEBP evidence rating scales, this meta-analysis review has a strength of evidence rating 
of I and a quality rating of A/high, making the results of this review very pertinent and applicable 
to clinical practice (Newhouse et al., 2005).   
Additional Evidence 
 Qualitative study:  Ingram, Wessel, & Courneya (2010) researched women’s 
“perceptions of participating in a structured, home-based exercise program while receiving 
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adjuvant chemotherapy for breast cancer, including perceptions of facilitators of and challenges 
to exercise” (p. 239). The Participant Evaluation of Feasibility and Acceptability was used to 
collect both qualitative and quantitative data to for the study.  The participants maintained 
personal exercise logs and were contacted every-other-week by research assistants who inquired 
about the participants’ progress and modified their exercise prescriptions as necessary.  The most 
common exercise challenge encountered by the participants in Ingram et al.’s study was fatigue, 
specifically after receiving a chemotherapy dose.   
 The researchers of this study recognized that because the study was qualitative in nature 
and the sample size was small, it may be difficult to apply the results to a larger, more 
generalized population (Ingram et al., 2010).  However, the frequent contacts between the 
researchers and participants, in addition to the data being consistent that women with breast 
cancer receiving adjuvant chemotherapy “valued exercise and implemented a variety of 
strategies to maintain the exercise program” (Ingram et al., 2010, p. 241), the researchers do 
believe that the results may serve as a useful guide for oncology providers prescribing exercise 
as an intervention for cancer-related fatigue in women with non-metastatic breast cancer who are 
receiving adjuvant chemotherapy.  Using the JHNEBP evidence rating scales, this qualitative 
study has a strength of evidence rating of III and a quality rating of B/good (Newhouse et al., 
2005).   
Implications for Clinical Nursing Practice 
 The findings of this integrative review are consistent and help support the research 
question of “In women with non-metastatic breast cancer receiving adjuvant chemotherapy 
and/or radiation therapy, does the prescription of a home-based or supervised exercise program 
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versus usual care decrease the severity of cancer-related fatigue?”  Findings of this integrative 
review support the most recent recommendations by the National Comprehensive Cancer 
Network (2011) that screening for cancer-related fatigue should occur in every provider 
interaction with patients receiving treatment for non-metastatic breast cancer, and when CRF is 
identified, the incorporation of exercise in breast cancer patients’ treatment plans is an 
appropriate intervention to reduce this CRF.  The prescription of either a home-based or 
supervised exercise program that integrates low to moderate-intensity aerobic exercise in a 
regular frequency—at least 20 to 30 minutes per session, approximately three to five times per 
week—has shown to be effective in reducing CRF in breast cancer patients (Mock et al., 2005; 
Wang et al., 2011; Hsieh et al., 2008; Cramp, 2008; Velthius et al., 2010) and is an appropriate 
intervention for oncology providers to offer.   
 The incorporation of physical activity is an inexpensive, effective and low-risk 
intervention to combat CRF in patients with breast cancer (Velthius et al., 2010; Wang et al., 
2011).  The prescription of a home-based aerobic exercise program is a “widely applicable, 
feasible and acceptable” (Mock et al., 2005, p. 475) intervention for treating CRF in the breast 
cancer patient population.  Women participating in a home-based exercise program are able to 
scale back the intensity of their exercise or perform their full exercise program in multiple, 
shorter sessions if they are experiencing negative side effects of treatment, however, this may 
result in the exercise not be physically beneficial if the exercise intensity is too low (Velthius et 
al., 2010; Ingram et al., 2010).  Nonetheless, the incorporation of some exercise versus none 
poses benefits for patients during active cancer treatment as inactivity can lead to further muscle 
and cardiorespiratory decline (Velthius et al., 2010; Dimeo, 2001).   
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 Supervised exercise programs provide an opportunity for women to complete safe, 
monitored exercise and have their programs individualized and tailored if they experience side 
effects secondary to their cancer treatment (Hseih et al., 2008).  Breast cancer patients’ 
adherence to the exercise program is significantly higher when the exercise is supervised by 
physical therapists specialized in cancer exercise therapy (Hseih et al., 2008; NCCN, 2011).  
Specific patient situations which should trigger a referral to physical therapy to assist in exercise 
prescription include, but are not limited to: patients with comorbidities that affect 
cardiopulmonary function; patients in the immediate post-operative period; or patients who begin 
adjuvant treatment in a baseline deconditioned state (NCCN, 2011).  
 Women with breast cancer are often open to any and all suggested interventions to help 
them feel as best they can during active treatment; as a result, the inclusion of an exercise 
intervention is often well-received by breast cancer patients (Wang et al., 2011).  In addition to 
helping the patients feel better, participants in Wang et al.’s (2011) study noted that physical 
activity became a primary coping mechanism for the women’s cancer journey.  The results of 
Ingram et al.’s (2010) study also support this concept; when breast cancer patients are educated 
on the potential side effects associated with treatment and how to adjust their exercise program 
accordingly, they are more prepared for stressors of cancer treatment and how to cope with these 
stressors using an exercise program as a coping mechanism.  For the implementation of the 
exercise program to be effective, NCI (2012) recommends for providers to suggest the 
incorporation of activities that patients enjoy and specify implementation strategies for the 
patient so the exercise program can be realistically incorporated into the patients’ daily routine.  
In addition to prescribing exercise as an intervention for CRF, providing further non-
pharmacologic resources, such as participating in support groups, may provide beneficial effects 
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for the women receiving active treatment for breast cancer (NCCN, 2011).  This information is 
important for advanced practice registered nurses (APRNs) because our care is tailored to meet 
the holistic needs of our patients by providing interventions that have both physical and 
psychological effects.   
 The implementation of an exercise program into care of the patient receiving adjuvant 
treatment for non-metastatic breast cancer is dependent on the education of oncology providers 
by APRNs on the positive effect of exercise on reducing CRF (Santa Mina, Alibhai, Matthew, 
Guglietti, Steele, Trachtenberg, & Ritvo, 2012).  APRNs who are experienced and 
knowledgeable of this topic can present continuing education courses to educate oncology 
support staff and providers on the importance of incorporating of exercise into cancer care in 
addition to various implementation strategies to utilize in practice (Santa Mina et al., 2012).  The 
screening for CRF in this patient population should be encouraged with each provider 
interaction.  It is essential for an APRN to develop a policy and documentation procedure that 
notes the severity of CRF that all breast cancer patients report.  If moderate to severe CRF is 
present, a provider should have the knowledge and resources to determine the appropriate 
prescription of moderate-intensity exercise for the patient.  Patient education materials must be 
developed by APRNs who are experienced in prescribing exercise for CRF to assist their 
colleagues with communicating with their patients the importance of exercise to reduce the 
severity of CRF and other symptoms associated with a cancer diagnosis and treatment regimen 
(Santa Mina et al., 2012).  Finally, APRNs and oncology providers should seek to develop 
relationships with physical therapists and local, community-health facilities to provide 
opportunities for referrals to develop individualized exercise programs and provide a location for 
supervised group exercise classes for breast cancer patients (Santa Mina et al., 2012). 
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Summary and Recommendations 
 Findings of the six studies included in this integrative review support that APRNs ought 
to actively screen for cancer-related fatigue and when identified, prescribe appropriate, 
individualized exercise interventions and associated education on the effects of exercise on CRF.  
Further research should be completed to determine the most effective and least time-consuming 
method to screen for CRF in the outpatient setting so all patients with non-metastatic breast 
cancer can receive an intervention if they suffer from feelings of CRF (Velthius et al., 2010).  
Additional RCTs must be completed before definitive conclusions can be made, especially in 
regards to developing oncology-specific guidelines regarding intensity, duration and type of 
exercise therapy for the patient receiving active cancer treatment (Velthius et al., 2010; NCCN, 
2011).    
 Further research should be conducted to determine more specific types of exercise, such 
as the inclusion of resistance exercises and more specialized exercise programs that focus on 
both the mind and body, for example, yoga practice, and their effects on CRF (NCI, 2012).  
Additional recommendations on which patients are most appropriate for supervised exercise 
programs and when to refer patients to supervised exercise programs would be beneficial for the 
APRN in oncology practice.  The studies analyzed in this review included sample populations 
from various areas of the world; however, additional research conducted in the United States of 
more diverse, marginalized patient populations would provide evidence for APRNs to develop 
culturally-competent recommendations for exercise prescriptions to treat cancer-related fatigue 
in the non-metastatic breast cancer patient. 
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